Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Maria Pia Campagna"'
Autor:
Maria Pia Campagna, Alexandre Xavier, Jim Stankovich, Vicki E. Maltby, Mark Slee, Wei Z. Yeh, Trevor Kilpatrick, Rodney J. Scott, Helmut Butzkueven, Jeannette Lechner-Scott, Rodney A. Lea, Vilija G. Jokubaitis
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-17 (2023)
Abstract Background Pregnancy in women with multiple sclerosis (wwMS) is associated with a reduction of long-term disability progression. The mechanism that drives this effect is unknown, but converging evidence suggests a role for epigenetic mechani
Externí odkaz:
https://doaj.org/article/c83b1c0994ab46739590aea977c8c377
Autor:
Alexandre Xavier, Maria Pia Campagna, Vicki E. Maltby, Trevor Kilpatrick, Bruce V. Taylor, Helmut Butzkueven, Anne-Louise Ponsonby, Rodney J. Scott, Vilija G. Jokubaitis, Rodney A. Lea, Jeannette Lechner-Scott
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionMultiple Sclerosis (MS) has a complex pathophysiology that involves genetic and environmental factors. DNA methylation (DNAm) is one epigenetic mechanism that can reversibly modulate gene expression. Cell specific DNAm changes have been a
Externí odkaz:
https://doaj.org/article/3334d6c0582046ef85948439dcd87ba5
Autor:
Alexandre Xavier, Vicki E. Maltby, Ewoud Ewing, Maria Pia Campagna, Sean M. Burnard, Jesper N. Tegner, Mark Slee, Helmut Butzkueven, Ingrid Kockum, Lara Kular, Ausimmune/AusLong Investigators Group, Vilija G. Jokubaitis, Trevor Kilpatrick, Lars Alfredsson, Maja Jagodic, Anne-Louise Ponsonby, Bruce V. Taylor, Rodney J. Scott, Rodney A. Lea, Jeannette Lechner-Scott
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 16, p 12576 (2023)
Epigenetic mechanisms can regulate how DNA is expressed independently of sequence and are known to be associated with various diseases. Among those epigenetic mechanisms, DNA methylation (DNAm) is influenced by genotype and the environment, making it
Externí odkaz:
https://doaj.org/article/b6c041e6f786429eb7d451e38c715228
Autor:
Vilija G Jokubaitis, Maria Pia Campagna, Omar Ibrahim, Jim Stankovich, Pavlina Kleinova, Fuencisla Matesanz, Daniel Hui, Sara Eichau, Mark Slee, Jeannette Lechner-Scott, Rodney Lea, Trevor J Kilpatrick, Tomas Kalincik, Philip L De Jager, Ashley Beecham, Jacob L McCauley, Bruce V Taylor, Steve Vucic, Louise Laverick, Karolina Vodehnalova, Maria-Isabel García-Sanchéz, Antonio Alcina, Anneke van der Walt, Eva Kubala Havrdova, Guillermo Izquierdo, Nikolaos Patsopoulos, Dana Horakova, Helmut Butzkueven
Publikováno v:
Brain. 146:2316-2331
Multiple sclerosis is a leading cause of neurological disability in adults. Heterogeneity in multiple sclerosis clinical presentation has posed a major challenge for identifying genetic variants associated with disease outcomes. To overcome this chal
Autor:
Alexandre Xavier, Vicki E Maltby, Ewoud Ewing, Maria Pia Campagna, Sean Michael Burnard, Jesper N Tegner, Mark Slee, Helmut Butzkueven, Ingrid Kockum, Lara Kular, Vilija G Jokubaitis, Trevor Kilpatrick, Lars Alfredsson, Maja Jagodic, Anne-Louise Ponsonby, Bruce Taylor, Rodney John Scott, Rodney A Lea, Jeannette Lechner-Scott
Multiple sclerosis is a complex autoimmune disease that causes neuronal demyelination and debilitating physical and cognitive symptoms. Epigenetic factors can mediate genetic and environmental effects on disease risk. Here we profiled blood-based DNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53dafd935123749105a19d83048fbcf3
https://doi.org/10.21203/rs.3.rs-2570500/v1
https://doi.org/10.21203/rs.3.rs-2570500/v1
Autor:
Maria Pia Campagna, Alexandre Xavier, Rodney A. Lea, Jim Stankovich, Vicki E. Maltby, Helmut Butzkueven, Jeannette Lechner-Scott, Rodney J. Scott, Vilija G. Jokubaitis
Publikováno v:
Clinical Epigenetics. 14
Background The variation in multiple sclerosis (MS) disease severity is incompletely explained by genetics, suggesting genetic and environmental interactions are involved. Moreover, the lack of prognostic biomarkers makes it difficult for clinicians
Autor:
Helmut Butzkueven, Vilija Jokubaitis, Jim Stankovich, Maria Pia Campagna, Michael Zhong, Anneke van der Walt
Publikováno v:
Neurotherapeutics
There are a broad range of disease-modifying therapies (DMTs) available in relapsing-remitting multiple sclerosis (RRMS), but limited biomarkers exist to personalise DMT choice. All DMTs, including monoclonal antibodies such as rituximab and ocrelizu
Autor:
Maria Pia Campagna, Alexandre Xavier, Jeannette Lechner-Scott, Vicky Maltby, Rodney J. Scott, Helmut Butzkueven, Vilija G. Jokubaitis, Rodney A. Lea
Publikováno v:
Clinical Epigenetics
The aetiology and pathophysiology of complex diseases are driven by the interaction between genetic and environmental factors. The variability in risk and outcomes in these diseases are incompletely explained by genetics or environmental risk factors
Autor:
Jim Stankovich, Olga Skibina, Maria Pia Campagna, Robb Wesselingh, Cassie Nesbitt, Michael Zhong, Louise Rath, Janene Richards, Anneke van der Walt, Viet Bui Minh, Vilija Jokubaitis, Helmut Butzkueven, Denise McCarthy, Julian Ellis, Mastura Monif, Wei Zhen Yeh
Publikováno v:
Int J MS Care
Background: People with multiple sclerosis and neuroimmunologic disorders (herein referred to as patients) are increasingly treated with infusible monoclonal antibodies. This rise in demand has placed increased loads on current infusion services and